Glaab T - Search Results

1

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators. Vogelmeier C, et al. Among authors: glaab t. N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378. N Engl J Med. 2011. PMID: 21428765 Free article. Clinical Trial.

2

Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients.

Vogelmeier C, Fabbri LM, Rabe KF, Beeh KM, Schmidt H, Metzdorf N, Glaab T. Vogelmeier C, et al. Among authors: glaab t. Respir Med. 2013 Jan;107(1):75-83. doi: 10.1016/j.rmed.2012.09.015. Epub 2012 Oct 26. Respir Med. 2013. PMID: 23102611 Free article. Clinical Trial.

3

Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial.

Rabe KF, Fabbri LM, Vogelmeier C, Kögler H, Schmidt H, Beeh KM, Glaab T. Rabe KF, et al. Among authors: glaab t. Chest. 2013 Mar;143(3):711-719. doi: 10.1378/chest.12-1277. Chest. 2013. PMID: 23188489 Clinical Trial.

4

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.

Beeh KM, Glaab T, Stowasser S, Schmidt H, Fabbri LM, Rabe KF, Vogelmeier CF. Beeh KM, et al. Among authors: glaab t. Respir Res. 2013 Oct 29;14(1):116. doi: 10.1186/1465-9921-14-116. Respir Res. 2013. PMID: 24168767 Free PMC article. Clinical Trial.

5

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.

Rabe KF, Fabbri LM, Israel E, Kögler H, Riemann K, Schmidt H, Glaab T, Vogelmeier CF. Rabe KF, et al. Among authors: glaab t. Lancet Respir Med. 2014 Jan;2(1):44-53. doi: 10.1016/S2213-2600(13)70248-0. Epub 2013 Dec 5. Lancet Respir Med. 2014. PMID: 24461901 Clinical Trial.

6

Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations.

Beeh KM, Hederer B, Glaab T, Müller A, Rutten-van Moelken M, Kesten S, Vogelmeier C. Beeh KM, et al. Among authors: glaab t. Int J Chron Obstruct Pulmon Dis. 2009;4:119-25. Epub 2009 Apr 15. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19436693 Free PMC article. Clinical Trial.

7

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Kardos P, Wencker M, Glaab T, Vogelmeier C. Kardos P, et al. Among authors: glaab t. Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9. doi: 10.1164/rccm.200602-244OC. Epub 2006 Oct 19. Am J Respir Crit Care Med. 2007. PMID: 17053207 Clinical Trial.

8

Is there a role for antiinflammatory treatment in COPD?

Beeh KM, Glaab T. Beeh KM, et al. Among authors: glaab t. COPD. 2009 Oct;6(5):395-403. doi: 10.1080/15412550903143901. COPD. 2009. PMID: 19863369 Free article. Review.

9

[Early treatment of COPD with tiotropium].

Buhl R, Welte T, Vogelmeier C, Gillissen A, Voshaar T, Kögler H, Liu D, Glaab T. Buhl R, et al. Among authors: glaab t. Pneumologie. 2012 Oct;66(10):589-95. doi: 10.1055/s-0032-1310281. Epub 2012 Sep 25. Pneumologie. 2012. PMID: 23011771 Free article. Clinical Trial. German.

10

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Glaab T, Vogelmeier C, Buhl R. Glaab T, et al. Respir Res. 2010 Jun 17;11(1):79. doi: 10.1186/1465-9921-11-79. Respir Res. 2010. PMID: 20565728 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters